TELA Bio (TELA) EBITDA Margin (2018 - 2026)
TELA Bio (TELA) recorded quarterly EBITDA Margin of 64.43% in Q1 2026, down 48.71% quarter-over-quarter from 43.32% in Q4 2025, and down 361.0% on a YoY basis from 24.68% in Q1 2025.
TELA Bio (TELA) EBITDA Margin (2018 - 2026) Analysis & Trends
TELA Bio's EBITDA Margin history runs 9 years deep, the most recent figure standing at 64.43% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 361.0% year-over-year to 64.43%; the TTM figure through Mar 2026 stood at 49.31% (up 1170.0% YoY), while the FY2025 annual figure was 48.37%, up 623.0% from the prior year.
- EBITDA Margin was 64.43% for Q1 2026 at TELA Bio, down from 43.32% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 34.06% in Q1 2024 to a low of 119.6% in Q1 2022.
- Historically, EBITDA Margin has averaged 69.84% across 5 years, with a median of 72.46% in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin jumped 6718 bps in 2024, then plunged 2676 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 81.22% in 2022, then climbed by 6 bps to 76.09% in 2023, then surged by 31 bps to 52.51% in 2024, then advanced by 17 bps to 43.32% in 2025, then slumped by 49 bps to 64.43% in 2026.
- The last three EBITDA Margin figures came in at 64.43% (Q1 2026), 43.32% (Q4 2025), and 41.59% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | -64.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.43% |
| Dec 31, 2025 | -43.32% |
| Sep 30, 2025 | -41.59% |
| Jun 30, 2025 | -49.12% |
| Mar 31, 2025 | -60.82% |
| Dec 31, 2024 | -52.51% |
| Sep 30, 2024 | -54.44% |
| Jun 30, 2024 | -78.30% |
| Mar 31, 2024 | -34.06% |
| Dec 31, 2023 | -76.09% |
| Sep 30, 2023 | -72.46% |
| Jun 30, 2023 | -74.69% |
| Mar 31, 2023 | -101.24% |
| Dec 31, 2022 | -81.22% |
| Sep 30, 2022 | -85.02% |
| Jun 30, 2022 | -98.38% |
| Mar 31, 2022 | -119.60% |
| Dec 31, 2021 | -91.40% |
| Sep 30, 2021 | -94.29% |
| Jun 30, 2021 | -96.73% |